MGNX
Price
$1.58
Change
-$0.12 (-7.02%)
Updated
Jun 12, 04:09 PM (EDT)
Capitalization
107.88M
61 days until earnings call
PEPG
Price
$1.46
Change
+$0.01 (+0.69%)
Updated
Jun 12, 04:16 PM (EDT)
Capitalization
47.45M
56 days until earnings call
Interact to see
Advertisement

MGNX vs PEPG

Header iconMGNX vs PEPG Comparison
Open Charts MGNX vs PEPGBanner chart's image
MacroGenics
Price$1.58
Change-$0.12 (-7.02%)
Volume$907
Capitalization107.88M
PepGen
Price$1.46
Change+$0.01 (+0.69%)
Volume$100
Capitalization47.45M
MGNX vs PEPG Comparison Chart
Loading...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MGNX vs. PEPG commentary
Jun 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGNX is a StrongBuy and PEPG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 12, 2025
Stock price -- (MGNX: $1.71 vs. PEPG: $1.45)
Brand notoriety: MGNX and PEPG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGNX: 274% vs. PEPG: 84%
Market capitalization -- MGNX: $107.88M vs. PEPG: $47.45M
MGNX [@Biotechnology] is valued at $107.88M. PEPG’s [@Biotechnology] market capitalization is $47.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $353.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGNX’s FA Score shows that 0 FA rating(s) are green whilePEPG’s FA Score has 1 green FA rating(s).

  • MGNX’s FA Score: 0 green, 5 red.
  • PEPG’s FA Score: 1 green, 4 red.
According to our system of comparison, PEPG is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGNX’s TA Score shows that 6 TA indicator(s) are bullish while PEPG’s TA Score has 5 bullish TA indicator(s).

  • MGNX’s TA Score: 6 bullish, 3 bearish.
  • PEPG’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MGNX is a better buy in the short-term than PEPG.

Price Growth

MGNX (@Biotechnology) experienced а +14.00% price change this week, while PEPG (@Biotechnology) price change was -3.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.45%. For the same industry, the average monthly price growth was +16.95%, and the average quarterly price growth was +8.36%.

Reported Earning Dates

MGNX is expected to report earnings on Aug 12, 2025.

PEPG is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+6.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGNX($108M) has a higher market cap than PEPG($47.4M). MGNX YTD gains are higher at: -47.385 vs. PEPG (-61.741). MGNX has higher annual earnings (EBITDA): -57.37M vs. PEPG (-92.49M). MGNX has more cash in the bank: 202M vs. PEPG (120M). PEPG has less debt than MGNX: PEPG (18.7M) vs MGNX (37.5M). MGNX has higher revenues than PEPG: MGNX (148M) vs PEPG (0).
MGNXPEPGMGNX / PEPG
Capitalization108M47.4M228%
EBITDA-57.37M-92.49M62%
Gain YTD-47.385-61.74177%
P/E RatioN/AN/A-
Revenue148M0-
Total Cash202M120M168%
Total Debt37.5M18.7M201%
FUNDAMENTALS RATINGS
MGNX: Fundamental Ratings
MGNX
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MGNXPEPG
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 25 days ago
83%
Bullish Trend 16 days ago
87%
Declines
ODDS (%)
Bearish Trend 16 days ago
87%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROAD104.662.28
+2.23%
Construction Partners
ICE177.501.97
+1.12%
Intercontinental Exchange
LTC35.530.27
+0.77%
LTC Properties
SMTI28.94-0.86
-2.89%
Sanara MedTech
SRFM2.40-0.11
-4.38%
Surf Air Mobility

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with CRBU. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
-3.93%
CRBU - MGNX
52%
Loosely correlated
-3.28%
XNCR - MGNX
49%
Loosely correlated
-2.26%
RGNX - MGNX
46%
Loosely correlated
+3.98%
KOD - MGNX
46%
Loosely correlated
-4.50%
CRSP - MGNX
46%
Loosely correlated
-3.31%
More

PEPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PEPG has been loosely correlated with SLDB. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PEPG jumps, then SLDB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEPG
1D Price
Change %
PEPG100%
-3.33%
SLDB - PEPG
36%
Loosely correlated
-4.55%
MGNX - PEPG
36%
Loosely correlated
-3.93%
FENC - PEPG
31%
Poorly correlated
-1.32%
IMTX - PEPG
31%
Poorly correlated
+0.34%
XNCR - PEPG
31%
Poorly correlated
-2.26%
More